SMTL ID : 5u6i.1

Discovery of MLi-2, an Orally Available and Selective LRRK2 Inhibitor that Reduces Brain Kinase Activity

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x 81Y: 3-[2-(morpholin-4-yl)pyridin-4-yl]-5-[(propan-2-yl)oxy]-1H-indazole(Non-covalent)

81Y.1: 22 residues within 4Å: Chain A: I.37, G.38, E.39, G.40, V.45, S.47, A.58, K.60, I.90, Q.111, D.112, L.113, M.114, E.115, T.116, D.117, K.120, S.159, N.160, L.162, C.172, D.173 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.37, A:I.37, A:V.45, A:A.58, A:L.113 Hydrogen bonds: A:D.112, A:M.114, A:K.120

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 7 residues within 4Å: Chain A: R.76, R.178, V.179, D.338, M.339, E.340, L.341 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:V.179, A:D.338, A:M.339 Water bridges: A:R.76, A:L.341 Salt bridges: A:R.76, A:R.178 SO4.3: 6 residues within 4Å: Chain A: R.73, R.154, R.178, Y.193, V.194, Y.211 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.73, A:Y.211 Water bridges: A:R.154, A:V.194 Salt bridges: A:R.154, A:R.178 SO4.4: 4 residues within 4Å: Chain A: Y.193, R.197, R.200, Y.239 6 PLIP interactions: 6 interactions with chain A Water bridges: A:R.197, A:R.200, A:R.200, A:Y.239 Salt bridges: A:R.197, A:R.200 SO4.5: 2 residues within 4Å: Chain A: G.188, K.265 6 PLIP interactions: 6 interactions with chain A Water bridges: A:G.188, A:G.188, A:K.265, A:K.265, A:K.265 Salt bridges: A:K.265

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Scott, J.D. et al., Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity. J. Med. Chem. (2017)

Release Date

2017-03-15

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence